Marko launches in New Zealand with personalised blood insights
A new health platform named Marko has launched in New Zealand, offering people personalised insights based on their blood test results to support preventative health and wellness strategies.
Marko has been developed by clinical nutritionist Vinka Wong and Sheree Hart, aiming to transform how individuals understand their health through data-driven recommendations.
The platform operates by analysing over 30 different blood markers, with data sourced from accredited laboratories. This information is then converted into tailored nutrition, lifestyle, and supplement plans intended to help users optimise their wellbeing.
Marko's approach to blood analysis differs from standard methodologies by utilising narrower, research-based ranges drawn from data on healthy individuals. The platform's creators state that these narrower reference ranges offer deeper insight by highlighting smaller variances that could contribute to optimising health, rather than simply identifying illness.
The service is delivered through a personal online dashboard. Users receive a bespoke health score reflecting their body function, and through an annual membership, they are able to track their scores and health progress over time, following their individual action plans and opting to re-test as needed.
Deepening personal understanding
Vinka Wong, Marko Co-Founder and Clinical Nutritionist, highlighted the need for such a tool among New Zealanders seeking agency over their health. She said: "We have access to more information than ever before, but we have very little understanding of our personal needs and what will actually make us feel remarkable. Marko's mission is to empower individuals with a holistic view of their health alongside practical, easy-to-understand strategies specific to their blood markers," Wong says.
She further outlined the scope of Marko's recommendations: "Marko will highlight where an individual is thriving and where there's opportunity for improvement. It's not just about identifying deficiencies and potential concerns, it's about recommending the right foods, positive lifestyle changes, and personalised supplement regimes for maximum impact."
In addition to a general overview, users may focus their analysis on specific health categories. These currently span energy, immune system, inflammation, metabolism, heart health, liver health, gut health, kidney health, mental health, and vitamin D levels.
Primary healthcare system pressures
The launch of Marko comes amid sustained pressures on New Zealand's primary healthcare services, which are facing challenges including a shortage of general practitioners. Marko's creators say their preventative and holistic focus can help identify potential concerns before they develop into full illnesses, potentially reducing demands on the healthcare system.
Wong elaborated on this point in her statement: "When individuals take control of their health and wellness, they can reduce their instances of needing to see a GP and ultimately ease the pressure on our healthcare system. This is not just a movement for individuals, it's about encouraging each other to stop letting health take a back seat."
To ensure accuracy and scientific validity, Marko has been developed with input from doctors, nutritionists, and naturopaths, and its analysis processes are informed by thousands of medical studies.
The Marko platform is available to users via annual membership, which includes access to blood marker analysis, health scoring, and ongoing tracking capabilities as individuals work towards improved health outcomes.
As New Zealand's population increasingly seeks control over health and wellness, digital tools like Marko are entering the market to fill demand for personalised preventative approaches grounded in blood biomarker data.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
1News
an hour ago
- 1News
GPs, nurses able to diagnose, treat ADHD from next year
GPs and nurse practitioners will soon be able to diagnose and treat patients with Attention-Deficit Hyperactivity Disorder (ADHD), it has been announced. Under the current system, GPs and nurses can only prescribe ADHD stimulant medicines on a written recommendation from a paediatrician or psychiatrist or after the patient has already been previously diagnosed with ADHD. Pharmac's acting director of advice and assessment Catherine Epps said that the new rules decided by Pharmac and Medsafe will mean that, over time, more GPs and nurses will be able to diagnose people with ADHD and start treatment. "The decision, which is based on feedback from psychiatrists, paediatricians, GPs, nurse practitioners and patients, is one of many changes we are making to increase access to ADHD medicines," said Epps. For children and adolescents, the changes will enable nurse practitioners working within child health or mental health services to diagnose and initiate treatment for ADHD. ADVERTISEMENT Medsafe group manager Chris James said that New Zealand has a workforce of highly experienced GPs and nurse practitioners, with many already working closely with specialists to treat patients with ADHD. "Implementing this change will mean they can do this work more quickly and efficiently without needing to wait for approval from a specialist," James said. Minister for Mental Health Matt Doocey applauded the decision and said it was a step forward for patient support and system efficiency. The morning's headlines in 90 seconds including Iran's retaliation, Auckland Council's catering cost, and the new way to look deep into space. (Source: 1News) "This is a common-sense change that will make a meaningful difference in many lives of New Zealanders," Doocey said. "I have heard stories of many people with ADHD who have been unable to get a diagnosis and treatment in a timely manner because of long wait items and costs associated with seeing a specialist." Earlier this year, Medsafe and Pharmac received feedback from more than 940 people and organisations on the proposed change. ADVERTISEMENT The Ministry of Health said that most of the feedback was supportive, and people believed the decision would improve access to diagnosis and treatment. However, some people were concerned about supply issues affecting the availability of methylphenidate. To address this, health agencies have delayed the implementation date from July 2025 to February 2026. This will also allow GPs and nurse practitioners more time to develop further clinical expertise in ADHD. Doocey said that the Ministry of Health is working with sector representatives to develop a clinical principles framework for the assessment and treatment of ADHD which will ensure quality and consistency for supporting patients. "We have heard your feedback loud and clear, and we know the positive impact this decision will have on many people's ability to access what is often life-changing medicines."
Scoop
7 hours ago
- Scoop
New Stats NZ Groundwater Reporting Highlights Serious Risk To Public From Govt Proposal To Weaken Freshwater Protections
Stats NZ's latest groundwater reporting shows New Zealanders are already at risk from contaminated drinking water sources and highlights the threat to the public should the Government continue with its proposals to weaken policy that protects freshwater, says campaign group Choose Clean Water. 'The Government is consulting on plans to remove the prioritisation of the health of waterways and protection of drinking water sources in current freshwater policy and instead change it to give power to commercial polluters of freshwater. 'Given the state of our groundwater, where many of our communities draw their drinking water from, this Government proposal will inevitably increase the health risks to people. It's unbelievably irresponsible.' says Choose Clean Water spokesperson Tom Kay. The new Stats NZ groundwater quality reporting presents monitoring data for groundwater sites across the country between 2019 and 2024. It shows the Maximum Allowable Values for New Zealand drinking water were exceeded at least once between April 2019 and March 2024 at 45.1 percent of sites (450 of 998) for E. coli and 12.4 percent of sites (146 of 1173) for nitrate. Almost half of the monitoring sites show likely or very likely increasing trends in nitrate. Stats NZ says groundwater provides drinking water to nearly half of the population. 'Healthy water bodies provide safe, good quality drinking water. Where groundwater quality is contaminated, we need strong policy that prioritises the public interest in healthy water. Otherwise, communities will struggle to access safe, good quality drinking water at a manageable cost. 'Treating contaminated drinking water, particularly for nitrate contamination, is expensive, complicated, and not very effective. Some communities are already dealing with this as a result of pollution from commercial interests and the Government is proposing to further open the door to commercial interests to dramatically increase their pollution of a fundamental public need,' says Kay. High levels of nitrate in Waimate's drinking water supply in December last year led to a do-not-drink notice for many households. In 2022, a report estimated that treating Christchurch's water supply for potentially high nitrate levels in future could cost $610 million to construct and $24 million per year to operate. The Government's consultation document on freshwater policy is open for submissions until 27 July. The consultation document proposes to remove national bottom lines for pollution as well as to remove or rewrite Te Mana o te Wai, the decision making framework in current national policy that prioritises the public interest in healthy water bodies. 'Rewriting Te Mana o te Wai or removing it from policy would have the same effect. It would take legal priority away from the public interest in healthy water and give more power to polluters by putting private commercial interests on par with people's drinking water. 'It's immoral but consistent with this Government's approach - look at the decisions on tobacco, for example. The Government is demonstrating it cares more about harmful commercial industries than it does about the health of its people.'
Otago Daily Times
8 hours ago
- Otago Daily Times
GPs able to diagnose, treat ADHD from February
GPs and nurse practitioners will soon be allowed to diagnose and treat ADHD. File photo GPs and nurse practitioners have been given the green light to diagnose and treat ADHD from February next year. Currently, they require the written recommendation of a psychiatrist or paediatrician to start prescribing ADHD medications, which can takes months. Medsafe and Pharmac announced a rule change, on Tuesday, following a long campaign from GPs and mental health advocates. Mental Health Minister Matt Doocey applauded the "common-sense change" and said it would make a meaningful difference in many New Zealanders' lives. "I have heard stories of many people with ADHD who have been unable to get a diagnosis and treatment in a timely manner because of long wait items and costs associated with seeing a specialist," he said. "I want to acknowledge the many advocates with lived experience who have spent years pushing for this change." Health agencies have set the start date at February 2026 to address potential supply issues related to methylphenidate, also known as Ritalin, and to give more time for workforce preparation. Patients under 18 will be able to begin treatment with sign-off from a nurse practitioner working within a multidisciplinary setting as part of paediatric or child and adolescent mental health services. In a statement, Medsafe group manager Chris James said the move would improve access to ADHD treatment for the public. "We have a workforce of highly experienced general practitioners and nurse practitioners, a number of whom are already working closely with specialists to treat patients with ADHD. Implementing this change will mean they can do this work more quickly and efficiently without needing to wait for approval from a specialist." James said it would be important to maintain a "high quality of ADHD assessment". "We have been working closely with sector representatives to develop a clinical framework which will set out principles for diagnosing and treating ADHD, including the appropriate clinical care required of healthcare practitioners," James said. Last year, Pharmac also removed the requirement for funded access to stimulant medicines to be renewed every two years and is funding a new ADHD medicine, lisdexamfetamine.
